Document Detail

Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial.
MedLine Citation:
PMID:  21959255     Owner:  NLM     Status:  Publisher    
Aims: The aim of this study was to compare the efficacy and safety of zotarolimus-eluting stents (ZES), sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).Methods and results: This study was a prospective, single-blind, multicentre, randomised trial. The primary endpoint was major adverse cardiac events (MACE) at 12 months post-procedure, defined as cardiac death, recurrent myocardial infarction (MI), or ischaemia-driven target lesion revascularisation (TLR). An angiographic substudy was performed at nine months among 348 patients. From October 2006 to April 2008, 611 patients with STEMI undergoing primary PCI were randomly assigned to treatment with ZES (n=205), SES (n=204), or PES (n=202). The cumulative incidence of MACE was 5.9% in the ZES group, 3.4% in the SES group and 5.7% in the PES group at 12-month follow-up (p=0.457). There was a trend towards a lower rate of ischaemia-driven TLR at 12- (p=0.092) and 18-month (p=0.080) follow-up in the SES group compared to the ZES and PES groups. No difference was observed in rates of cardiac death, recurrent MI and combined death and/or recurrent MI among three groups at 12- and 18-month follow-up. The rate of stent thrombosis was similar among the three groups (2.0% in each group, p=1.000).Conclusions: As compared with SES and PES, the use of ZES in patients with STEMI undergoing primary PCI, showed similar rates of MACE, cardiac death and recurrent MI at 12 and 18 months. There was a trend towards a higher rate of TLR with ZES or PES compared to SES.
Woong Chol Kang; Taehoon Ahn; Kyounghoon Lee; Seung Hwan Han; Eak Kyun Shin; Myung Ho Jeong; Jung Han Yoon; Jong Sun Park; Jang Ho Bae; Seung Ho Hur; Seung Woon Rha; Seok Kyu Oh; Doo Il Kim; Yangsoo Jang; Jae Woong Choi; Byung Ok Kim
Related Documents :
15663915 - Ace inhibitors and mineralocorticoid receptor blockade in patients with congestive hear...
22910755 - Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on ca...
22394355 - Histologic remission of cardiac amyloidosis: a case report.
22139085 - Implementation of pharmacotherapy guidelines in heart failure: experience from the germ...
8149525 - Use of therapeutic ultrasound in percutaneous coronary angioplasty. experimental in vit...
10085495 - Subacute stent thrombosis occurring more than one month after implantation for acute my...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-1
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  -     ISSN:  1969-6213     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Gil Hospital. Gachon University of Medicine and Science, Incheon, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reliability and smallest real difference of the ankle lunge test post ankle fracture.
Next Document:  The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: The ...